150 related articles for article (PubMed ID: 17249203)
1. Evaluation of spectral selected press sequence in breast lesion characterization.
Lu H; Liu PF; Bao RX; Sun F
Chin Med Sci J; 2006 Dec; 21(4):265-9. PubMed ID: 17249203
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
[TBL] [Abstract][Full Text] [Related]
3. In vivo 1H-MRS evaluation of malignant and benign breast diseases.
Kim JK; Park SH; Lee HM; Lee YH; Sung NK; Chung DS; Kim OD
Breast; 2003 Jun; 12(3):179-82. PubMed ID: 14659324
[TBL] [Abstract][Full Text] [Related]
4. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
5. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy--initial results.
Yeung DK; Cheung HS; Tse GM
Radiology; 2001 Jul; 220(1):40-6. PubMed ID: 11425970
[TBL] [Abstract][Full Text] [Related]
6. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
[TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
[TBL] [Abstract][Full Text] [Related]
9. Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.
Başara I; Örgüç Ş; Coşkun T
Diagn Interv Radiol; 2013; 19(3):221-6. PubMed ID: 23271501
[TBL] [Abstract][Full Text] [Related]
10. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.
Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA
NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970
[TBL] [Abstract][Full Text] [Related]
11. [Differentiation between benign and malignant breast lesions using fat-suppressed dynamic MR imaging].
Koshiishi T; Isomoto I; Nakamura K; Kajiwara Y; Izawa K
Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Jul; 58(8):433-40. PubMed ID: 9745257
[TBL] [Abstract][Full Text] [Related]
12.
Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
[TBL] [Abstract][Full Text] [Related]
13. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
14. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Yeung DK; Yang WT; Tse GM
Radiology; 2002 Oct; 225(1):190-7. PubMed ID: 12355004
[TBL] [Abstract][Full Text] [Related]
16. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy.
Bartella L; Thakur SB; Morris EA; Dershaw DD; Huang W; Chough E; Cruz MC; Liberman L
Radiology; 2007 Oct; 245(1):80-7. PubMed ID: 17885182
[TBL] [Abstract][Full Text] [Related]
17. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
18. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
19. 1H MR spectroscopy and diffusion-weighted imaging of the breast: are they useful tools for characterizing breast lesions before biopsy?
Tozaki M; Fukuma E
AJR Am J Roentgenol; 2009 Sep; 193(3):840-9. PubMed ID: 19696300
[TBL] [Abstract][Full Text] [Related]
20. [Application of dynamic contrast enhancement MRI and post-processing technique for diagnosis of breast cancer].
Peng KQ; Huang ZL; Xie CM; Chen L; Ouyang Y; Zheng QS; Zhang Y; He HQ; Wu PH
Ai Zheng; 2009 May; 28(5):549-54. PubMed ID: 19624888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
